Antiviral host defense through selective translational inhibition
$294,500R01FY2015GMNIH
University Of California, San Diego, La Jolla CA
Investigators
Linked publications & trials
Abstract
DESCRIPTION (provided by applicant): HIV continues to be one of the most prevalent infectious diseases in this world. Our discovery of a novel cellular factor that inhibits the production of HIV by infected cells provides a new target for the development of a novel class of anti-viral drugs and may additionally carry diagnostic and prognostic value. Furthermore, based on the molecular basis of the antiviral activity we hypothesize that other viruses such as Influenza will also be subject to inhibition by huSlfn11.
View original record on NIH RePORTER →